EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Désirée van der Heijde, Iain B. McInnes et al.|Annals of the Rheumatic Diseases|2020Cited by 2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Désirée van der Heijde, Robert Landewé et al.|Annals of the Rheumatic Diseases|2022Cited by 1.9k
2022 updateJosef S Smolen, Josef S. Smolen, Robert Landewé et al.|Radboud Repository (Radboud University)|2010Cited by 1.6k